Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis

Published:2019-07 Issue: Volume:139 Page:16-23
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Guo Xi,Sun Hong,Dong Jihong,Feng Yi,Li Hong,Zhuang Rongyuan,Wang Peipei,Cai Weimin,Zhou Yuhong

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference48 articles.

1. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B;Akerley;Cancer,2003

2. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: a gynecologic oncology group study;Alberts;Gynecol. Oncol..,2012

3. Peripheral nerve damage associated with administration of taxanes in patients with cancer;Argyriou;Crit. Rev. Oncol./Hematol.,2008

4. Intraperitoneal cisplatin and, 2019 intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006

5. A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non–small-cell lung cancer;Camidge;J. Thorac. Oncol..,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-09

2. Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST);Scientific Reports;2024-08-22

3. Factors affecting peripheral neuropathy induced by nanoparticle albumin‐bound paclitaxel in patients with pancreatic cancer;British Journal of Clinical Pharmacology;2024-08-16

4. Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer;Journal of Cancer Research and Clinical Oncology;2024-06-25

5. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study;Medicine;2024-03-01